END POINT | PATIENTS, N (%) | EFFECT RELATIVE (95% CI)* | ABSOLUTE NO. PER 1 000 000 (95% CI) | |
---|---|---|---|---|
KQ1 SCREENING (N = 69 942) | CONTROL, NO SCREENING (N = 75 499) | |||
Composite | 1951 (2.8)† | 2275 (3.0)† | RR 0.91 (0.86 to 0.97) | 2712 fewer (904 fewer to 4219 fewer) |
Acute myocardial infarction | 667 (1.0)† | 816 (1.1)† | RR 0.87 (0.79 to 0.97) | 1405 fewer (324 fewer to 2270 fewer) |
Congestive heart failure | 735 (1.1)† | 923 (1.2)† | RR 0.90 (0.81 to 0.99) | 1223 fewer (122 fewer to 2323 fewer) |
Stroke | 550 (0.8)† | 536 (0.7)† | RR 0.99 (0.88 to 1.12) | 71 fewer (852 fewer to 852 more) |
All-cause mortality | 2377 (3.4)‡ | 2608 (3.5)‡ | RR 0.98 (0.92 to 1.04) | 684 fewer (2618 fewer to 1368 more) |
KQ1—key question 1, RCT—randomized controlled trial, RR—relative risk.
↵* These outcomes represent the effect of the Cardiovascular Health Awareness Program. Outcome measures reported have been adjusted for hospital admission rates in the year before the intervention.
↵† Calculations based on mean cumulative admissions.
↵‡ Calculations based on the number of unique admissions.
Data from Kaczorowski et al.15